Skip to content
Life Science Washington

Life Science Washington

An independent, non-profit 501(c)(6) trade association serving the life sciences industry in the state of Washington.

  • Membership
  • Events
  • About
  • Policy & Resources
  • Career Center
  • News
  • LSW Institute
  • Member Sign In

Category: Funding

  • All
  • Research
  • COVID
  • Funding
  • Jobs
  • All
  • Research
  • COVID
  • Funding
  • Jobs
Funding

Tune Therapeutics launches with $40M in funding, aims to fine-tune activity of genes in cells

  • Posted onDecember 6, 2021 Last Updated: December 6, 2021
  • By: Kaitlyn Grosse
Funding

Cell Therapy Startup Immusoft Lands Deal With Takeda Worth Potentially More Than $900M

  • Posted onOctober 18, 2021 Last Updated: October 18, 2021
  • By: Kaitlyn Grosse
Funding

Seattle Biotech Alpine Immune Sciences Raises $91M for Drug Development

  • Posted onSeptember 20, 2021 Last Updated: September 20, 2021
  • By: Kaitlyn Grosse
Funding

Startup A-Alpha Bio Sets Out To Solve A Major Protein Problem Facing Big Pharma

  • Posted onSeptember 13, 2021 Last Updated: September 13, 2021
  • By: Kaitlyn Grosse
Funding

Life-Sciences Investment Volume Hit $9B in First Half of 2021, Tracking To a Record Year for CRE Sector

  • Posted onSeptember 7, 2021 Last Updated: September 7, 2021
  • By: Kaitlyn Grosse
Funding

Biotech Companies Fuel IPO Boom in Washington State Over the Past Year

  • Posted onAugust 30, 2021 Last Updated: August 30, 2021
  • By: Kaitlyn Grosse
Funding

In Washington’s Life Sciences Sector, A Streak of Companies Going Public

  • Posted onAugust 9, 2021 Last Updated: August 9, 2021
  • By: Kaitlyn Grosse
Funding

Icosavax Stock Skyrockets 200% on First Day of Trading for Newly Public Seattle Biotech Company

  • Posted onAugust 2, 2021 Last Updated: August 2, 2021
  • By: Kaitlyn Grosse
Funding

Absci Shares Spike 30% in IPO Debut, Valuing Washington State Biotech Company at Nearly $2B

  • Posted onJuly 26, 2021 Last Updated: July 26, 2021
  • By: Kaitlyn Grosse
Funding

Eliem Therapeutics Files for IPO as Another Seattle-Area Biotech Firm Set to Go Public

  • Posted onJuly 26, 2021 Last Updated: July 26, 2021
  • By: Kaitlyn Grosse
  • 1
  • 2
  • 3
  • 4
  • 5
Stay Connected.
  • Twitter
  • Facebook
  • LinkedIn

Find out first about industry news, upcoming events and updates by signing up for our newsletter. Log in here to subscribe to our members-only newsletter which includes invitations and insider tips.


Life Science Washington

188 East Blaine St, Suite 150
Seattle, WA 98102

Main: (206) 456-9567
Fax: (206) 456-9561

  • About Us
  • Events
  • Membership
  • Policy & Resources
  • Career Center
  • News
Contact Us
Advertising
© 2022 Life Science Washington
Website Designed + Built by Wildern.
  • Membership
  • Events
  • About
  • Policy & Resources
  • Career Center
  • News
  • LSW Institute
  • Member Sign In